“Clearing Opacity through Machine Learning”

Nicholson Price
  • AI, Law, and Technology
Iowa Law Review
2021

“Problematic Interactions between AI and Health Privacy”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Utah Law Review
2021

“How Much Can Potential Jurors Tell Us About Liability for Medical Artificial Intelligence?”

Nicholson Price
  • AI, Law, and Technology
Journal of Nuclear Medicine January
2021

“Negative Innovation: When Patents are Bad for Patients”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature Biotechnology
2021

"Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships"

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Vaccine
2021

“Regulatory Responses to Medical Machine Learning”

Nicholson Price
Journal of Law and the Biosciences
2020

“Regulatory Oversight, Causal Inference, and Safe and Effective Health Care Machine Learning”

Nicholson Price
Biostatistics
2020

“Knowledge Transfer for Large-Scale Vaccine Manufacturing”

Nicholson Price
Science
2020

“Covid-19, Single-Sourced Diagnostic Tests, and Innovation Policy”

Nicholson Price
  • Health Law
Journal of Law and the Biosciences
2020

“The Cost of Novelty”

Nicholson Price
  • Intellectual Property and Antitrust
  • AI, Law, and Technology
Columbia Law Review
2020

“Diagnosing Bias in Data-Driven Algorithms for Healthcare”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature Medicine
2020

“Privacy Gaps for Digital Cardiology Data: Big Problems With Big Data”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Circulation
2020

“Potential Liability for Physicians Using Artificial Intelligence”

Nicholson Price
Journal of the American Medical Association
2019

Risks and Remedies for Artificial Intelligence in Healthcare

Nicholson Price
2019

“Grants”

Nicholson Price
  • AI, Law, and Technology
Berkeley Technology Law Journal
2019

“Health Care AI: Law, Regulation, and Policy”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril
2019

“Privacy in the Era of Medical Big Data”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature Medicine
2019

“Biobanks as Innovation Infrastructure for Translational Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Global Genes, Local Concerns: Legal, Ethical, and Scientific Challenges in International Biobanking
2019

“How Logically Impossible Patents Block Biosimilars”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature Biotechnology
2019

“Shadow Health Records Meet New Data Privacy Laws”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Science
2019

“Medical AI and Contextual Bias”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Harvard Journal of Law & Technology
2019

“Artificial Intelligence in the Medical System: Four Roles for Potential Transformation”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Yale Journal of Law and Technology
2019

“Medical Malpractice and Black-Box Medicine”

Nicholson Price
  • Health Law
Big Data, Health Law, and Bioethics
2018

“Big Data and Black-Box Medical Algorithms”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Science Translational Medicine
2018

“Drug Approval in a Learning Health System”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Minnesota Law Review
2018

“Promoting Healthcare Innovation on the Demand Side”

Nicholson Price Rebecca S. Eisenberg
  • Intellectual Property and Antitrust
  • AI, Law, and Technology
Journal of Law and the Biosciences
2017

“Risk and Resilience in Health Data Infrastructure”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Colorado Technology Law Journal
2017

“Regulating Black-Box Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Michigan Law Review
2017

“Artificial Intelligence in Health Care: Applications and Legal Issues”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
The SciTech. Lawyer
2017

“Expired Patents, Trade Secrets, and Stymied Competition”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Notre Dame Law Review
2017

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

Nicholson Price
Journal of Diabetes Science and Technology
2016

“Manufacturing Barriers to Biologics Competition and Innovation”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Iowa Law Review
2016

“Privacy and Accountability in Black-Box Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Michigan Telecommunications and Technology Law Review
2016

“Big Data, Patents, and the Future of Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Cardozo Law Review
2016

“Regulating Secrecy”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Washington Law Review
2016

“Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature
2016

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Journal of Diabetes Science and Technology
2016

“Describing Black-Box Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Boston University Journal of Science & Technology Law
2015

“Black-Box Medicine”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Harvard Journal of Law & Technology
2015

“Innovation Policy Failures in the Manufacturing of Drugs”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Are Trade Secrets Delaying Biosimilars?”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Science
2015

“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Nature Biotechnology
2015

“Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Boston College Law Review
2014

“Patent Trolling - Why Bio & Pharmaceuticals Are at Risk”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Stanford Technology Law Review
2014

“Models of Consent to Return of Incidental Findings in Genomic Research”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Hastings Center Report
2014

“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
IP Theory
2014

“Nudging the FDA”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
The American Interest
2014

“Legal Implications of an Ethical Duty to Search for Genetic Incidental Findings”

Nicholson Price
The American Journal of Bioethics
2013

“Informed Consent for Return of Incidental Findings in Genomic Research”

Nicholson Price
  • AI, Law, and Technology
  • Health Law
Genetics in Medicine
2013